Lindbrook Capital’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $393 | Buy |
69
+44
| +176% | +$251 | ﹤0.01% | 2661 |
|
|
2024
Q4 | $246 | Hold |
25
| – | – | ﹤0.01% | 2702 |
|
|
2024
Q3 | $204 | Hold |
25
| – | – | ﹤0.01% | 2769 |
|
|
2024
Q2 | $334 | Sell |
25
-27
| -52% | -$361 | ﹤0.01% | 2677 |
|
|
2024
Q1 | $2.39K | Sell |
52
-147
| -74% | -$6.76K | ﹤0.01% | 2177 |
|
|
2023
Q4 | $13.4K | Sell |
199
-4
| -2% | -$270 | ﹤0.01% | 1382 |
|
|
2023
Q3 | $14.7K | Sell |
203
-85
| -30% | -$6.17K | ﹤0.01% | 1210 |
|
|
2023
Q2 | $21.4K | Buy |
288
+109
| +61% | +$8.1K | ﹤0.01% | 1055 |
|
|
2023
Q1 | $9.51K | Buy |
179
+172
| +2,457% | +$9.14K | ﹤0.01% | 1485 |
|
|
2022
Q4 | $502 | Buy |
7
+5
| +250% | +$359 | ﹤0.01% | 2600 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2686 |
|